Management team

Management team

Andreas Bhagwani

CEO since 2011
andreas.bhagwani@nanologica.com

Education and training:

MBA from Stockholm School of Economics, studies in agronomy at the Swedish University of Agricultural Sciences in Uppsala.

Main experience:

Andreas is the co-founder of several companies, the most recent being Sigrid Therapeutics AB (obesity therapy) and Atrogi AB (diabetes). Andreas has worked as a management consultant for over a decade, specializing in sales and leadership. In addition to the above companies, he is a co-founder of WideNarrow, Kichisaga Leadership (management consultancy) and GenderTimer (cell phone app).

Other assignments:

Board member and owner of Vega Bianca AB, board member of Nanghavi AB, deputy board member and co-owner of Kichisaga Leadership AB, as well as co-owner of Atrogi AB and Sigrid Therapeutics AB.

Holds 1,586,398 shares through the company Vega Bianca AB.

Eva Osterman

CFO since 2017
eva.osterman@nanologica.com

Education and training:

Master of Science in Business Administration and Economics from Uppsala University.

Main experience:

Eva has many years of experience in finance at larger companies. She has worked within business control, financial control, reporting and internal audit. She also has extensive experience from major international firms in the pharmaceutical industry.

 

Other assignments:

Deputy board member of Nanghavi AB och Consensor AB.

Holds 57,283 shares.

Adam Feiler, CTO

Adam Feiler

CTO since 2012

Education and training:

Doctorate in physical chemistry from The Ian Wark Research Institute at the University of South Australia, Adelaide, Australia.

Main experience:

Adam has nearly two decades’ academic research experience in the area of nanoparticles, biomaterials and medical implants. His experience also includes a broad range of analytical methodologies within microscopy and spectroscopy. Adam also has several years’ industrial experience from the Institute for Surface Chemistry (currently SP Chemistry, Materials and Surfaces) as head of research and business manager. Whilst there he was in charge of managing contract research projects within the pharmaceutical, cosmetics and food industries.

Other assignments:

Adjunct professor at the Royal Institute of Technology (KTH), Stockholm.

Holds 1,000 shares.

Anna-Karin Renström, Director Operations and Strategies

Anna-Karin Renström

Director  Operations and Strategies  since 2019              

Education and training:

MSHc Industrial Engineering and Management, Business Performance Diploma and Executive Management Program, Stockholm School of Economics, Certification in Board work, Styrelsekraft via ALMI

Main experience:

Anna-Karin has been the CEO of Telge Inköp for 10 years before joining Nanologica. She has also held the positions as Chairman for Telge Kraft AB and board member at Telge Nät AB. Before that she worked in various positions within purchasing and finance at AstraZeneca.

Other assignments:

No other assignments.

Holds 48,483 shares.

Kia Bengtsson

Director Drug Development since 2019

Education and training:

Registered nurse, Karolinska University
Hospital

Main experience:

Kia has more than 20 years’ experience from the pharmaceutical industry and clinical R&D whereof the last ten years in leading positions at Eurocine Vaccines, Ipsen and AstraZeneca.

Other assignments:

No other assignments.

 

Chunfang Zhou

Global Sales Director Chromatography since 2018

Education and training:

Post Doc. from the University of Aveiro in Portugal, Ph.D. in physical chemistry from Nanjing University in China, chemical engineer from Sichuan University in China

Main experience:

Chunfang has 17 years’ experience of nanoporous silica from chromatography as well as drug delivery. She did her PhD within the topic and has remained ever since, first as a scientist then as sales director.

Other assignments:

No other assignments.​